The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

Chan, clinical director of the Gastrointestinal Cancer Center and director of the Program in Carcinoid and Neuroendocrine Tumors at Dana-Farber Cancer Institute in Boston, led the trial. She spoke ...

New research to be presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) and published in The Journal of Internal Medicine shows that, in survivors of breast ...

A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in ...

Clinical Director of the Gastrointestinal Cancer Center and Director of the Program in Carcinoid and Neuroendocrine Tumors at Dana-Farber Cancer Institute. “This FDA approval marks a meaningful ...

Mar. 13, 2025 — A study shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United States ...

Physicians classify brain tumors and determine treatment options, in part, by the genes they express. According to World Health Organization standards, the abnormal activation of oncogene FOXR2 ...

Foods to avoid can include alcohol, caffeine, and spicy or fatty foods. Recommendations can vary, however, depending on the type of irritable bowel syndrome. FODMAPs (fermentable oligosaccharides, ...

However, this doesn't mean that low levels of thyroid hormone mean a person will gain weight (or conversely that high levels ... Thyroid and Parathyroid Hormones. National Cancer Institute. Thyroxine.

Trusted, comprehensive information and resources for autism.

Do freezing cold dips live up to the hype? Find out what the science says.